Efficacy and Safety of the Collagenase of the Bacterium Clostridium Histolyticum for the Treatment of Capsular Contracture after Silicone Implants: Ex-Vivo Study on Human Tissue.

The fibrotic capsule that surrounds silicone implants consists mainly of collagen. The FDA-approved collagenase of the bacterium clostridium histolyticum provides a reasonable treatment option. Safety and efficacy at the female breast site must be evaluated before clinical utilization.We incubated 2...

Full description

Bibliographic Details
Main Authors: Sebastian Fischer, Christoph Hirche, Yannick Diehm, Kristo Nuutila, Jurij Kiefer, Emre Gazyakan, Ericka M Bueno, Thomas Kremer, Ulrich Kneser, Bohdan Pomahac
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4883774?pdf=render
_version_ 1818990986984947712
author Sebastian Fischer
Christoph Hirche
Yannick Diehm
Kristo Nuutila
Jurij Kiefer
Emre Gazyakan
Ericka M Bueno
Thomas Kremer
Ulrich Kneser
Bohdan Pomahac
author_facet Sebastian Fischer
Christoph Hirche
Yannick Diehm
Kristo Nuutila
Jurij Kiefer
Emre Gazyakan
Ericka M Bueno
Thomas Kremer
Ulrich Kneser
Bohdan Pomahac
author_sort Sebastian Fischer
collection DOAJ
description The fibrotic capsule that surrounds silicone implants consists mainly of collagen. The FDA-approved collagenase of the bacterium clostridium histolyticum provides a reasonable treatment option. Safety and efficacy at the female breast site must be evaluated before clinical utilization.We incubated 20 samples of fibrotic capsule as well as 12 full thickness skin grafts harvested from the female breast site for 24 hours with different doses of collagenase. Outcome measures involved histological assessment of thickness and density of the capsule tissue as well as the skin grafts. Furthermore, we performed a collagen assay and immunohistochemistry staining for collagen subtypes.Collagenase treatment was able to degrade human capsule contracture tissue ex-vivo. The remaining collagen subtype after degradation was type 4 only. 0.3 mg/ml of collagenase was most effective in reducing capsule thickness when compared with higher concentrations. Of note, effectiveness was inversely related to capsule density, such that there was less reduction in thickness with higher capsule densities and vice versa. Furthermore, the application of 0.3mg/ml collagenase did not lead to thinning or perforation of full thickness skin grafts.Adjustment of collagenase dose will depend on thickness and density of the contracted capsule. A concentration of 0.3mg/ml seems to be safe and effective in an ex-vivo setting. The remaining collagen subtype 4 is suitable to serve as a neo-capsule/acellular tissue matrix. Collagenase treatment for capsular contracture may soon become a clinical reality.
first_indexed 2024-12-20T20:03:06Z
format Article
id doaj.art-41112f72022749e0837881ad64b6879f
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-20T20:03:06Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-41112f72022749e0837881ad64b6879f2022-12-21T19:28:00ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01115e015642810.1371/journal.pone.0156428Efficacy and Safety of the Collagenase of the Bacterium Clostridium Histolyticum for the Treatment of Capsular Contracture after Silicone Implants: Ex-Vivo Study on Human Tissue.Sebastian FischerChristoph HircheYannick DiehmKristo NuutilaJurij KieferEmre GazyakanEricka M BuenoThomas KremerUlrich KneserBohdan PomahacThe fibrotic capsule that surrounds silicone implants consists mainly of collagen. The FDA-approved collagenase of the bacterium clostridium histolyticum provides a reasonable treatment option. Safety and efficacy at the female breast site must be evaluated before clinical utilization.We incubated 20 samples of fibrotic capsule as well as 12 full thickness skin grafts harvested from the female breast site for 24 hours with different doses of collagenase. Outcome measures involved histological assessment of thickness and density of the capsule tissue as well as the skin grafts. Furthermore, we performed a collagen assay and immunohistochemistry staining for collagen subtypes.Collagenase treatment was able to degrade human capsule contracture tissue ex-vivo. The remaining collagen subtype after degradation was type 4 only. 0.3 mg/ml of collagenase was most effective in reducing capsule thickness when compared with higher concentrations. Of note, effectiveness was inversely related to capsule density, such that there was less reduction in thickness with higher capsule densities and vice versa. Furthermore, the application of 0.3mg/ml collagenase did not lead to thinning or perforation of full thickness skin grafts.Adjustment of collagenase dose will depend on thickness and density of the contracted capsule. A concentration of 0.3mg/ml seems to be safe and effective in an ex-vivo setting. The remaining collagen subtype 4 is suitable to serve as a neo-capsule/acellular tissue matrix. Collagenase treatment for capsular contracture may soon become a clinical reality.http://europepmc.org/articles/PMC4883774?pdf=render
spellingShingle Sebastian Fischer
Christoph Hirche
Yannick Diehm
Kristo Nuutila
Jurij Kiefer
Emre Gazyakan
Ericka M Bueno
Thomas Kremer
Ulrich Kneser
Bohdan Pomahac
Efficacy and Safety of the Collagenase of the Bacterium Clostridium Histolyticum for the Treatment of Capsular Contracture after Silicone Implants: Ex-Vivo Study on Human Tissue.
PLoS ONE
title Efficacy and Safety of the Collagenase of the Bacterium Clostridium Histolyticum for the Treatment of Capsular Contracture after Silicone Implants: Ex-Vivo Study on Human Tissue.
title_full Efficacy and Safety of the Collagenase of the Bacterium Clostridium Histolyticum for the Treatment of Capsular Contracture after Silicone Implants: Ex-Vivo Study on Human Tissue.
title_fullStr Efficacy and Safety of the Collagenase of the Bacterium Clostridium Histolyticum for the Treatment of Capsular Contracture after Silicone Implants: Ex-Vivo Study on Human Tissue.
title_full_unstemmed Efficacy and Safety of the Collagenase of the Bacterium Clostridium Histolyticum for the Treatment of Capsular Contracture after Silicone Implants: Ex-Vivo Study on Human Tissue.
title_short Efficacy and Safety of the Collagenase of the Bacterium Clostridium Histolyticum for the Treatment of Capsular Contracture after Silicone Implants: Ex-Vivo Study on Human Tissue.
title_sort efficacy and safety of the collagenase of the bacterium clostridium histolyticum for the treatment of capsular contracture after silicone implants ex vivo study on human tissue
url http://europepmc.org/articles/PMC4883774?pdf=render
work_keys_str_mv AT sebastianfischer efficacyandsafetyofthecollagenaseofthebacteriumclostridiumhistolyticumforthetreatmentofcapsularcontractureaftersiliconeimplantsexvivostudyonhumantissue
AT christophhirche efficacyandsafetyofthecollagenaseofthebacteriumclostridiumhistolyticumforthetreatmentofcapsularcontractureaftersiliconeimplantsexvivostudyonhumantissue
AT yannickdiehm efficacyandsafetyofthecollagenaseofthebacteriumclostridiumhistolyticumforthetreatmentofcapsularcontractureaftersiliconeimplantsexvivostudyonhumantissue
AT kristonuutila efficacyandsafetyofthecollagenaseofthebacteriumclostridiumhistolyticumforthetreatmentofcapsularcontractureaftersiliconeimplantsexvivostudyonhumantissue
AT jurijkiefer efficacyandsafetyofthecollagenaseofthebacteriumclostridiumhistolyticumforthetreatmentofcapsularcontractureaftersiliconeimplantsexvivostudyonhumantissue
AT emregazyakan efficacyandsafetyofthecollagenaseofthebacteriumclostridiumhistolyticumforthetreatmentofcapsularcontractureaftersiliconeimplantsexvivostudyonhumantissue
AT erickambueno efficacyandsafetyofthecollagenaseofthebacteriumclostridiumhistolyticumforthetreatmentofcapsularcontractureaftersiliconeimplantsexvivostudyonhumantissue
AT thomaskremer efficacyandsafetyofthecollagenaseofthebacteriumclostridiumhistolyticumforthetreatmentofcapsularcontractureaftersiliconeimplantsexvivostudyonhumantissue
AT ulrichkneser efficacyandsafetyofthecollagenaseofthebacteriumclostridiumhistolyticumforthetreatmentofcapsularcontractureaftersiliconeimplantsexvivostudyonhumantissue
AT bohdanpomahac efficacyandsafetyofthecollagenaseofthebacteriumclostridiumhistolyticumforthetreatmentofcapsularcontractureaftersiliconeimplantsexvivostudyonhumantissue